The judge said letting generics makers sell their versions before the
patent dispute was decided would damage the Swiss drugmaker more than
those wanting a piece of Gilenya's market.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-wins-gilenya-reprieve-as-judge-blocks-generics-for-now/articleshow/69947011.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment